Dysregulated activation and polarization of macrophages drive the pathogenesis of diverse diseases, including inflammatory, autoimmune, ischemic, metabolic disorders, and cancers.
Despite therapeutic advances, precise regulation of macrophage polarization remains challenging.
Natural products have recently emerged as promising therapeutic regulators.
Astragaloside IV (AS-IV) and its hydrolysate cycloastragenol (CAG), which are bioactive compounds derived from
